MarketInOut Stock Screener Log In | Sign Up

Liminatus Pharma Inc Wt

NASDAQ • Healthcare • Biotechnology • Quote as of 10/28/2026 09:31
Liminatus Pharma Inc Wt stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1.07 mln
Float1.02 mln
Earnings Date11/13/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

17 / 100
Significantly lagging

Debt / Equity

4.80
Highly leveraged

ROE

444
Extraordinary

ROA

-629
Deeply negative

Business Description

Liminatus Pharma is an early-stage drug development company focused on finding new ways to fight cancer. Founded in 2018 and headquartered in La Palma, California, the company is working on a specialized antibody designed to help the immune system recognize and attack tumor cells more effectively. Unlike some similar treatments, their approach is intended to avoid damaging red blood cells, which has been a common challenge in this area of research.

Key Fundamentals

EPS-23.70
ROE444
ROIC-197
ROA-629
Interest Cover-53.78
EBITDA, mln-4.06
EV / EBITDA-0.19

Quote Details

Last 0.04
Change 0 (0%)
Open 0.04
Volume 138
Turnover 5.52
Average Volume 2,465.86

Financial Ratios

Leverage Ratio11.32
Current Ratio1.12
Price / Book0.15
Debt / Equity4.80

Financial Strength

Piotroski F-Score 3 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -27.93% 1 / 100   
1 Month -39.58% 7 / 100   
2 Months 0% 59 / 100   
6 Months -70.8% 6 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog